Repeated Remote Ischemic Conditioning Protects Against Doxorubicin Cardiotoxicity: Never Too Much of a Good Thing

JACC CardioOncol. 2020 Mar 17;2(1):53-55. doi: 10.1016/j.jaccao.2020.02.001. eCollection 2020 Mar.

Derek J Hausenloy^{1

2

3

4

5

6}, Choon Ta Ng⁷, Jun Hua Chong^{2

7}

¹ National Heart Research Institute Singapore, National Heart Centre Singapore, Singapore.
² Cardiovascular & Metabolic Disorders Program, Duke-National University of Singapore Medical School, Singapore.
³ Yong Loo Lin School of Medicine, National University Singapore, Singapore.
⁴ The Hatter Cardiovascular Institute, University College London, London, United Kingdom.
⁵ Cardiovascular Research Center, College of Medical and Health Sciences, Asia University, Taichung City, Taiwan.
⁶ Tecnologico de Monterrey, Centro de Biotecnologia-FEMSA, Nuevo Leon, Mexico.
⁷ Department of Cardiology, National Heart Centre Singapore, Singapore.

No abstract available

Keywords: anthracycline cardiotoxicity; cardioprotection; chronic remote ischemic conditioning; repeat remote ischemic conditioning.

Publication types